Catalyst Pharmaceuticals Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Buy

CPRX
Catalyst Pharmaceuticals

Last Price:

$23.83

Seasonality Move:

15.63%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here

Catalyst Pharmaceuticals Stock Forecast

Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 30% based on the past 18 years of stock performance.
Catalyst Pharmaceuticals has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Is Catalyst Pharmaceuticals Stock Undervalued?

The current Catalyst Pharmaceuticals [CPRX] share price is $23.37. The Score for CPRX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
CPRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Catalyst Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 30% based on the past 18 years of stock performance.

Catalyst Pharmaceuticals Stock Rating

Buy

Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals overpriced?

Catalyst Pharmaceuticals has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Catalyst Pharmaceuticals Stock Price History

Is CPRX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

catalystpharma.com

52-Week Data

52-Week High:

26.16

52-Week Low:

14.75

Prediction Charts

Market Cap:

2.9B

Price in USD:

23.37

Volume:

1.6M

Beta:

1.09

Technical Analysis

SMA50:

23.02

SMA100:

22.59

SMA200:

21.44

52-Wk Change:

49.33%

Stock Predictions

Is Catalyst Pharmaceuticals stock public?

Yes, Catalyst Pharmaceuticals is a publicly traded company.
What is the Catalyst Pharmaceuticals stock quote today?

The Catalyst Pharmaceuticals stock price is 23.37 USD today.
How to buy Catalyst Pharmaceuticals stock online?

You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	22.40	22.60	22.93	22.36
Apr-23	23.15	23.12	23.52	23.00
Apr-24	23.15	23.19	23.40	23.04
Apr-25	23.12	23.45	23.51	22.90
Apr-28	23.53	23.63	24.19	23.36
Apr-29	23.53	24.28	24.46	23.41
Apr-30	24.28	24.29	24.61	24.01
May-1	24.28	24.27	24.65	23.81
May-2	24.37	24.84	25.01	24.37
May-5	24.78	24.30	24.83	24.18
May-6	24.01	23.06	24.18	22.94
May-7	23.10	23.46	23.59	23.00
May-8	23.17	22.76	23.17	20.80
May-9	23.06	23.37	23.70	22.89

Catalyst Pharmaceuticals Earnings

Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Catalyst Pharmaceuticals Forecast Revenue Growth

Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.14 per share, an increase this year of $0.20 per share, and an increase next year of $0.02 per share.

* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.